Notice for sirolimus, rapamycin (AFT Pharmaceuticals Limited)
Active ingredients
sirolimus, rapamycin
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
topical cream
Indication
Treatment of facial angiofibromas associated with Tuberous Sclerosis Complex (TSC)
Therapeutic area
Dermatology